Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab

User: Guest

Document type:: Zeitschriftenaufsatz
Author(s):: Kemmerer, C. L.; Pernpeintner, V.; Ruschil, C.; Abdelhak, A.; Scholl, M.; Ziemann, U.; Krumbholz, M.; Hemmer, B.; Kowarik, M. C.
Title:: Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab
Journal title:: PLOS ONE
Year:: 2020
Journal volume:: 15
Journal issue:: 7
Pages contribution:: e0235449
Fulltext / DOI:: doi:10.1371/journal.pone.0235449
Publisher:: Public Library of Science (PLoS)
E-ISSN:: 1932-6203
Date of publication:: 27.07.2020
BibTeX

Occurrences: